Correction: miR-17: from developmental regulatory hub to molecular engine driving tumourigenesis - Scorecard - MDSpire

Correction: miR-17: from developmental regulatory hub to molecular engine driving tumourigenesis

  • By

  • Min Zhang

  • Yurong Ma

  • XuanYu Chen

  • Tiansi Sun

  • XiYi Wang

  • Feng Hui Wang

  • June 15, 2026

  • 0 min

Share

Clinical Scorecard: Correction: miR-17's Role Transition from a Developmental Regulatory Center to a Key Driver of Tumorigenesis

At a Glance

CategoryDetail
ConditionTumorigenesis
Key MechanismsmiR-17 as a molecular engine driving tumorigenesis
Target PopulationPatients with tumors related to miR-17 dysregulation
Care SettingOncology

Key Highlights

  • Correction of author affiliations
  • Correction of author roles
  • No change in scientific conclusions

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified

          Not specified

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: miR-17: from developmental regulatory hub to molecular engine driving tumourigenesis

            • by Min Zhang, Yurong Ma, XuanYu Chen, Tiansi Sun, XiYi Wang, Feng Hui Wang

            • June 15, 2026

            Related Content

            Group painting therapy for children and adolescents with bone tumors: a quasi-experimental trial evaluating anxiety, depression, post-traumatic growth, and health-related quality of life

            Correction: The efficacy of angiogenesis inhibitors combined with chemotherapy in advanced breast cancer: a systematic review and meta-analysis

            Intensified MR-guided pulsed adaptive cancer treatment- a potential new treatment option for large(>5cm) central non-small cell lung cancer, a case report